gujarat terce laboratories ltd Share Price
GUJTERC
₹0.00-₹0.00 (0%) Past Year
₹0.00₹0.00
LH
What’s in news?
No data available at the moment
Company overview
About
Market cap
| Open₹0.00 | Close₹-- |
Circuit range₹-- - ₹-- | Day range₹0.00 - ₹0.00 | Year range₹-- - ₹-- |
Volume-- | Avg. traded₹-- | Revenue (12m)₹NaN undefined |
Gujarat Terce Laboratories LtdGujarat Terce Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of medicines and healthcare products. Its diverse portfolio encompasses approximately 70 brands and 180 stock-keeping units (SKUs) covering multiple dosage forms, such as tablets, capsules, oral liquids, ointments and injectables. The Company offers therapies in areas of antibiotics, gynecology, respiratory, nutraceuticals, gastrointestinal and anti-fungal. The Company’s brands include Acolate, Codimol, Resplash, Terflora Z, Thyter, Tynol, Z-Oxi, and Vitfol. The Company has approximately eight brands occupying a space in the top 10 in various therapeutic areas. The Company has a presence in over 13 states in India. The Company also has a presence in Eastern and Western Africa, the association of Southeast Asian Nations (ASEAN), and Latin American (LATAM) countries.
Read more
Gujarat Terce Laboratories Ltd Key indicators
52 week high₹0.00 | 52 week low₹0.00 | P/E ratio |
P/B ratio | ROEN/A | ROCEN/A |
Dividend yieldN/A | Debt/Equity ratio | EPS |
Learn more
Fundamentals
Financial ratios
Operating profit marginN/A | Net profit marginN/A |
ROEN/A | ROAN/A |
ROCEN/A |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
Gujarat Terce Laboratories Ltd Share Price history
Day | Open | Close | Day’s change |
---|
Events
No data available at the moment
More
Similar stocks
People also bought
Investment calculators
Upcoming IPOs
No data available at the moment